300+ investors in your industry, stage, and region Get
Any industry
Video Games
Hospitality
EdTech
Restaurants
Google
Construction
Photography
Cryptocurrency
Clean Energy
Big Data
Email
Artificial Intelligence
Social Impact
SaaS
Energy
Mobile
Consumer
Health Care
Enterprise Software
Local
Platforms
Travel
InsurTech
CleanTech
Oil and Gas
Payments
Retail
Film
Fitness
Marketplace
Organic Food
Machine Learning
Agriculture (AgTech)
Gaming
Blockchain
Facebook
Social Network
B2B
Medical Device
Education
Wellness
Sports
Automotive
eSports
Legal
Biotechnology
Software
Renewable Energy
Crowdfunding
Venture Capital
Social
Infrastructure
Beauty
Fashion
Climate
LGBT
Cannabis
Celebrity
Life Science
Food and Beverage
Publishing
Mobile Apps
Wine and Spirits
Music
Art
Real Estate
Sporting Goods
Manufacturing
FinTech
Finance
Digital Media
Social Media
Financial Services
Franchise
Non Profit
Internet
Mobile Advertising
Android
Proptech
Impact
Sustainability
Hardware
Biotech
Transportation
Enterprise
Community
Media (Entertainment)
Recruiting
Web3
Medical
Theatre
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
South Korea
Japan
Burkina Faso
Africa
Singapore
Brazil
LATAM
Gibraltar
Egypt
Taiwan
Hong Kong
Nigeria
Togo
Croatia
Iran
Guinea
Haiti
Kyrgyzstan
Norway
Lesotho
Isle of Man
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Sudan
Pakistan
Tajikistan
Zambia
Zimbabwe
Romania
Tunisia
Sweden
Oceania
Poland
Oman
Puerto Rico
Cameroon
Guernsey
Colombia
Armenia
China
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Australia
Saudi Arabia
Sri Lanka
Jamaica
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Morocco
Moldova
Seychelles
Botswana
Paraguay
Canada
South Africa
France
Denmark
Georgia
Ghana
Iraq
Latvia
Mali
Malaysia
Philippines
Portugal
Rwanda
Sierra Leone
El Salvador
Senegal
Tanzania
Ireland
India
Germany
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Europe
Argentina
Qatar
Angola
Cyprus
Barbados
Belgium
Jordan
Ethiopia
Austria
Azerbaijan
Bulgaria
Ecuador
Faroe Islands
Jersey
Bahrain
Estonia
Bahamas
Bolivia
Belize
Algeria
Italy
Belarus
Finland
Hungary
Grenada
Israel
Lithuania
Honduras
Iceland
Cambodia
Liechtenstein
Lebanon
Mongolia
Bangladesh
Peru
Slovenia
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
Shaanxi Investment Capital, VC Fund

Shaanxi Investment Capital

VC Fund

Xian, China

Shaanxi Investment Capital is a VC fund in Xian focused on Manufacturing and Biotechnology. Shaanxi Investment Growth Fund is an investment firm.

Total investments:
20
Last investment:
Lead investor:
30%

Last updated:

Industries Shaanxi Investment Capital invests in

ManufacturingBiotechnologyMedicalAdvanced MaterialsBiopharma

Stages Shaanxi Investment Capital invests in

Series BSeedSeries ASeries CVenture - Series Unknown

Countries Shaanxi Investment Capital invests in

China

Investment Focus

Industry

  • Manufacturing 6 (30%)
  • Biotechnology 5 (25%)
  • Medical 4 (20%)
  • Advanced Materials 3 (15%)
  • Biopharma 2 (10%)
See all 29 industries →

Stage

  • Series B 6 (30%)
  • Seed 5 (25%)
  • Series A 5 (25%)
  • Series C 1 (5%)
  • Venture - Series Unknown 1 (5%)

Investments

CompanyDescriptionRoundLinks
Zhonghui Medicine
Zhonghui Medicine is the first hollow microneedle research and development and production company in China with independent intellectual property rights. $7M / Seed / Jun 09, 2025
Jingwei New Materials Jingwei New Materials
Jingwei New Materials is a copper alloy material manufacturer that makes copper-based and associated auxiliary new materials. Seed / Jun 12, 2024
Bio Regenmed Bio Regenmed
Bioregeneration is a national high-tech industrial firm that creates and manufactures innovative biomedical materials with the goal of human tissue engineering and organ repair. Series C / Dec 28, 2023
Neurodome Neurodome
Neurodome is a manufacturer of non-invasive deep brain nerve modulation technology. It focuses on the research and development of non-invasive deep brain nerve modulation products. Seed / Dec 27, 2023
Rongcan Bio Rongcan Bio
Rongcan Bio completes the nucleic acid industry chain from nucleic acid sequence design, mRNA nucleic acid raw material synthesis, delivery carrier synthesis, and final drug delivery. It is a nucleic acid drug development and industrialization service provider. $14M / Series A / Dec 06, 2023
GeneRulor GeneRulor
GeneRulor is a biomedical company that offers molecular diagnostics and gene editing technology services for viral infections and related tumor diseases. Series A / Sep 05, 2023
Solidarity Solidarity
Solid New Materials is a high-energy density battery core material developer. Seed / Jun 01, 2023
Zhilun Ultra-Pure Zhilun Ultra-Pure
Zhilun Ultra-Pure is a high-tech firm that combines high-quality resources, works autonomously, and is distinguished by "specialization, precision, and special innovation" by three technology-based new material companies. It is dedicated to ultra-high-purity electronic-grade epoxy. The Electronic Chemical New Material IndustryAlliance's governing unit is R&D and production and sales resin. Seed / May 22, 2023
Blueray Med Blueray Med
Blueray Med medical device enterprise focusing on a new generation of optomechanical computing. It has established a 2000M² GMP standard production base in Caotang Industrial Park, Xi'an High-tech Zone. The world's first blue laser laser surgery system has been developed, which will be used for the operation of superficial diseases in thecavity and the surgical treatment of other diseases in urology. The product line includes high, medium and low power blue laser surgical systems and consumables. The world's first blue laser surgery system has been granted the Class III registration certificate issued by the State Drug Administration on November 16, 2021, and the world's most powerful 200W blue laser surgery system has been granted the National Drug Administration on April 6, 2022 Three types of registration certificates issued by the Authority. The company will begin to obtain EU CE product certification in 2023, providing cost-effective, safe and effective medical devices for domestic and foreign hospitals. Series A / Apr 12, 2023
Blueray Med Blueray Med
Blueray Med medical device enterprise focusing on a new generation of optomechanical computing. It has established a 2000M² GMP standard production base in Caotang Industrial Park, Xi'an High-tech Zone. The world's first blue laser laser surgery system has been developed, which will be used for the operation of superficial diseases in thecavity and the surgical treatment of other diseases in urology. The product line includes high, medium and low power blue laser surgical systems and consumables. The world's first blue laser surgery system has been granted the Class III registration certificate issued by the State Drug Administration on November 16, 2021, and the world's most powerful 200W blue laser surgery system has been granted the National Drug Administration on April 6, 2022 Three types of registration certificates issued by the Authority. The company will begin to obtain EU CE product certification in 2023, providing cost-effective, safe and effective medical devices for domestic and foreign hospitals. Series A / Apr 12, 2023
See all 20 investments →

Co-Investors

Shaanxi Investment Growth Fund 4 deals together
CAS Star CAS Star 2 deals together Guangzhou Yuexiu Industrial Investment Fund Guangzhou Yuexiu Industrial Investment Fund 2 deals together
Hefei Zhonghe Opple Medical and Health Industry fund 2 deals together
Xi'an Caijin Xi'an Caijin 2 deals together Addor Capital Addor Capital 1 deal together

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Video Games
Hospitality
EdTech
Restaurants
Google
Construction
Photography
Cryptocurrency
Clean Energy
Big Data
Email
Artificial Intelligence
Social Impact
SaaS
Energy
Mobile
Consumer
Health Care
Enterprise Software
Local
Platforms
Travel
InsurTech
CleanTech
Oil and Gas
Payments
Retail
Film
Fitness
Marketplace
Organic Food
Machine Learning
Agriculture (AgTech)
Gaming
Blockchain
Facebook
Social Network
B2B
Medical Device
Education
Wellness
Sports
Automotive
eSports
Legal
Biotechnology
Software
Renewable Energy
Crowdfunding
Venture Capital
Social
Infrastructure
Beauty
Fashion
Climate
LGBT
Cannabis
Celebrity
Life Science
Food and Beverage
Publishing
Mobile Apps
Wine and Spirits
Music
Art
Real Estate
Sporting Goods
Manufacturing
FinTech
Finance
Digital Media
Social Media
Financial Services
Franchise
Non Profit
Internet
Mobile Advertising
Android
Proptech
Impact
Sustainability
Hardware
Biotech
Transportation
Enterprise
Community
Media (Entertainment)
Recruiting
Web3
Medical
Theatre
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
South Korea
Japan
Burkina Faso
Africa
Singapore
Brazil
LATAM
Gibraltar
Egypt
Taiwan
Hong Kong
Nigeria
Togo
Croatia
Iran
Guinea
Haiti
Kyrgyzstan
Norway
Lesotho
Isle of Man
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Sudan
Pakistan
Tajikistan
Zambia
Zimbabwe
Romania
Tunisia
Sweden
Oceania
Poland
Oman
Puerto Rico
Cameroon
Guernsey
Colombia
Armenia
China
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Australia
Saudi Arabia
Sri Lanka
Jamaica
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Morocco
Moldova
Seychelles
Botswana
Paraguay
Canada
South Africa
France
Denmark
Georgia
Ghana
Iraq
Latvia
Mali
Malaysia
Philippines
Portugal
Rwanda
Sierra Leone
El Salvador
Senegal
Tanzania
Ireland
India
Germany
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Europe
Argentina
Qatar
Angola
Cyprus
Barbados
Belgium
Jordan
Ethiopia
Austria
Azerbaijan
Bulgaria
Ecuador
Faroe Islands
Jersey
Bahrain
Estonia
Bahamas
Bolivia
Belize
Algeria
Italy
Belarus
Finland
Hungary
Grenada
Israel
Lithuania
Honduras
Iceland
Cambodia
Liechtenstein
Lebanon
Mongolia
Bangladesh
Peru
Slovenia
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does Shaanxi Investment Capital invest in?

Shaanxi Investment Capital invests primarily in Manufacturing, Biotechnology and Medical startups, most often at Series B and Seed stage. Most of the 20 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

When did Shaanxi Investment Capital last invest?

The most recent investment recorded for Shaanxi Investment Capital closed in Jun 2025. Shizune tracks 20 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
Shaanxi Investment Capital Shaanxi Investment Capital Find emails